- Report
- February 2024
- 180 Pages
Global
From €4352EUR$4,969USD£3,777GBP
- Report
- January 2025
- 142 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2024
- 211 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- December 2024
- 150 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 95 Pages
Philippines
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2023
- 85 Pages
United States
From €4248EUR$4,850USD£3,687GBP
- Report
- July 2024
- 89 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- September 2024
- 78 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- July 2024
- 103 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- November 2023
- 89 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- April 2022
- 84 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- January 2026
- 45 Pages
Global
From €258EUR$295USD£224GBP
- Report
- January 2025
- 132 Pages
Global
From €832EUR$950USD£722GBP
- Report
- January 2025
- 132 Pages
Global
From €832EUR$950USD£722GBP
- Report
- January 2025
- 132 Pages
Global
From €832EUR$950USD£722GBP

The Autoimmune Disease market within the context of Allergy and Immunology is a rapidly growing field of medical research and treatment. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment for autoimmune diseases typically involves immunosuppressive drugs, which reduce the activity of the immune system, and biologics, which target specific parts of the immune system.
In recent years, the development of new treatments for autoimmune diseases has been a major focus of research and development in the Allergy and Immunology field. Companies in this market are focused on developing new treatments, such as monoclonal antibodies, small molecule drugs, and gene therapies. Examples of companies in this market include AbbVie, Amgen, Biogen, Celgene, Gilead, and Regeneron. Show Less Read more